Type 2 diabetes affects over 37 million Americans, with many struggling to achieve optimal blood sugar control despite available medications. Our Phase 3 clinical trial is evaluating a breakthrough once-weekly injection that could revolutionize diabetes management by offering superior glucose control with less frequent dosing than current daily medications.
This 16-week, randomized, double-blind, placebo-controlled trial is testing a novel GLP-1/GIP dual receptor agonist – a cutting-edge medication that works through two powerful mechanisms to control blood sugar and potentially promote weight loss. The medication has already shown promising results in over 3,000 participants in earlier trials.
Unlike older diabetes medications that only address one aspect of the disease, this investigational drug:
Week 1 – Screening Visit (3-4 hours)
Comprehensive medical evaluation including medical history review, physical examination, blood tests, EKG, and diabetes education. You’ll receive a continuous glucose monitor to track your blood sugar throughout the study. Compensation: $200
Weeks 2-5 – Weekly Visits (2 hours each)
Weekly visits for the first month to monitor your response to the medication and adjust dosing. Each visit includes vital signs, blood sugar review, and safety assessments. Compensation: $175 per visit
Weeks 8, 12 – Monthly Visits (2-3 hours each)
Monthly follow-ups with comprehensive testing including HbA1c, liver function, kidney function, and lipid panels. Compensation: $175 per visit
Week 16 – Final Visit (3 hours)
Complete final assessment with all baseline tests repeated to measure improvement. Receive your results and discuss next steps with the study doctor. Compensation: $300 plus $500 completion bonus
Throughout the study, you receive medical care that often exceeds what’s available in routine clinical practice:
Our participants come from all walks of life but share common characteristics:
This study follows strict FDA guidelines and is monitored by an independent safety board. The medication has been tested in previous trials with a well-established safety profile. Common side effects may include mild nausea or decreased appetite, which typically improve within 2-4 weeks. Serious side effects are rare (less than 2% of participants).
Your participation directly contributes to potentially bringing a new treatment option to millions of people with Type 2 diabetes. Data from this trial will be submitted to the FDA for approval consideration. Previous participants have told us they value:
If you’re interested in participating, the process is straightforward:
Join thousands of participants who have contributed to medical breakthroughs while receiving excellent care and compensation.
Receive compensation for your time and participation, with payments distributed throughout the study period.
Receive comprehensive health monitoring and care from board-certified physicians and research specialists.
Contribute to groundbreaking research that could help millions of people worldwide.
Receive individualized attention and monitoring that goes beyond typical care.
Access to education materials and lifestyle counseling from certified educators.
Join a community of participants making a difference in medical research and treatment development.
Check if you meet our study criteria. Our team will conduct a thorough screening to confirm eligibility.
⏰ Limited spots available - screening closes soon!
Free screening • No obligation • Confidential
Get answers to common questions about participating in our clinical trial
You'll visit our clinic 8 times over 16 weeks - an initial screening visit, then weekly for the first month, and monthly thereafter. Each visit typically takes 2-3 hours.
Yes, you'll continue your current diabetes medications as prescribed by your doctor. The study medication is added to your existing treatment, not a replacement.
We'll monitor your blood sugar levels, HbA1c, weight, blood pressure, and perform routine blood work. You'll also receive a continuous glucose monitor to track your levels at home.
The medication is investigational and not yet FDA approved for public use. However, it has been thoroughly tested for safety in earlier trial phases with over 3,000 participants.
Our medical team is available 24/7. Common side effects may include mild nausea or injection site reactions. You can withdraw from the study at any time, and all medical care related to side effects is provided free of charge.
Trusted by participants and regulatory authorities for our commitment to safety, ethics, and scientific rigor
Protocol reviewed and authorized by the Food and Drug Administration
Independent ethical oversight ensures participant safety and rights
Your privacy and personal health information are fully protected
Trusted by hundreds of participants in our research studies
Contact our research team today to learn more about the study and check your eligibility.
(818) 581-4101
Available 8 AM - 6 PM, Mon-Sun
16101 Ventura Blvd Suite 300
Encino, CA 91436
